Screener
Syndax Pharmaceuticals SNDX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-197154
FAQ
- What is Syndax Pharmaceuticals's operating margin?
- Syndax Pharmaceuticals (SNDX) reported operating margin of -102.8% in Q1 2026.
- How has Syndax Pharmaceuticals's operating margin changed year-over-year?
- Syndax Pharmaceuticals's operating margin increased by 86.9% year-over-year, from -786.6% to -102.8%.
- What is the long-term trend for Syndax Pharmaceuticals's operating margin?
- Over 3 years (2020 to 2025), Syndax Pharmaceuticals's operating margin has grown at a -67.7% compound annual growth rate (CAGR), from -4,708.2% to -158.2%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Syndax Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude